Facebook Pixel

Citalopram and Finasteride Recalled

By
 
Rate This

Citalopram, an anti-depressant, and Finasteride, a drug used to treat benign prostatic hyperplasia, or enlargement of the prostate gland, have both been recalled by the company Greenstone LLC due to mislabelling. This is because a third party manufacturer has put the wrong labels on the medication. Some of the Citalopram has been labeled as Finasteride.

Lot number FI0510058-A is affected. The bottles contain 90 tablets.
Finasteride should not be taken by pregnant women because it could cause reproductive abnormalities in a male fetus. The development of the external genitalia may be adversely affected. Therefore, if you are pregnant or may become pregnant and you have taken the wrong medication, please see your doctor immediately.

Citalopram is not suitable for patients who take monoamine oxidase inhibitors (MAOIs) or the drug pimozide. It is also not suitable for patients who have hypersensitivity to citalopram or to any of other ingredients in citalopram.
If you have a bottle of the affected lot number it should be returned to your pharmacist.

If you have had an adverse event related to this product, you can report it to the U.S. Food and Drug Administration online at:
www.fda.gov/medwatch/report.htm

Source: FDA

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy
Joanna Karpasea-Jones
Empowered
View Profile Send Message

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Tags: